Perfect Medical Health Management Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Perfect Medical Health Management wird ein jährliches Gewinn- und Umsatzwachstum von 11.6% bzw. 4.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 11.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 110% betragen.
Wichtige Informationen
11.6%
Wachstumsrate der Gewinne
11.2%
EPS-Wachstumsrate
| Consumer Services Gewinnwachstum | 21.4% |
| Wachstumsrate der Einnahmen | 4.8% |
| Zukünftige Eigenkapitalrendite | 110.0% |
| Analystenabdeckung | Low |
| Zuletzt aktualisiert | 18 Jul 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
At HK$2.27, Is Perfect Medical Health Management Limited (HKG:1830) Worth Looking At Closely?
Aug 18
This Analyst Just Downgraded Their Perfect Medical Health Management Limited (HKG:1830) EPS Forecasts
Jul 22Perfect Medical Health Management Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jul 19Sentiment Still Eluding Perfect Medical Health Management Limited (HKG:1830)
Apr 15Perfect Medical Health Management's (HKG:1830) Dividend Will Be HK$0.142
Nov 27Perfect Medical Health Management's (HKG:1830) Upcoming Dividend Will Be Larger Than Last Year's
Jul 11Is Now An Opportune Moment To Examine Perfect Medical Health Management Limited (HKG:1830)?
Jun 29Perfect Medical Health Management (HKG:1830) Is Reinvesting To Multiply In Value
May 31Perfect Medical Health Management's (HKG:1830) Shareholders Will Receive A Smaller Dividend Than Last Year
Nov 27Should You Investigate Perfect Medical Health Management Limited (HKG:1830) At HK$3.07?
Nov 08Bullish: This Analyst Just Lifted Their Perfect Medical Health Management Limited (HKG:1830) Outlook For This Year
Aug 14Perfect Medical Health Management's (HKG:1830) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 14Is Now An Opportune Moment To Examine Perfect Medical Health Management Limited (HKG:1830)?
May 10Perfect Medical Health Management's (HKG:1830) Upcoming Dividend Will Be Larger Than Last Year's
Dec 01Investors Shouldn't Overlook The Favourable Returns On Capital At Perfect Medical Health Management (HKG:1830)
Nov 01Perfect Medical Health Management (HKG:1830) Is Paying Out Less In Dividends Than Last Year
Aug 17Investors Shouldn't Overlook The Favourable Returns On Capital At Perfect Medical Health Management (HKG:1830)
Jul 25Perfect Medical Health Management (HKG:1830) Will Pay A Smaller Dividend Than Last Year
Jul 03Estimating The Intrinsic Value Of Perfect Medical Health Management Limited (HKG:1830)
Jun 28A Look Into Perfect Shape Medical's (HKG:1830) Impressive Returns On Capital
Apr 12Is Perfect Shape Medical Limited's (HKG:1830) 6.8% Dividend Worth Your Time?
Mar 10Trade Alert: The Founder Of Perfect Shape Medical Limited (HKG:1830), Kong Au-Yeung, Has Just Spent HK$11m Buying A Few More Shares
Feb 23What You Need To Know About Perfect Shape Medical Limited's (HKG:1830) Investor Composition
Feb 21Is Perfect Shape Medical Limited's (HKG:1830) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Feb 06Kong Au-Yeung Is The Founder of Perfect Shape Medical Limited (HKG:1830) And Just Spent HK$2.0m On Shares
Jan 22Trends At Perfect Shape Medical (HKG:1830) Point To A Promising Future
Jan 08
Perfect Shape Medical (HKG:1830) Has Rewarded Shareholders With An Exceptional 415% Total Return On Their Investment
Dec 24Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 3/31/2027 | 1,589 | 443 | 480 | 510 | 1 |
| 3/31/2026 | 1,469 | 402 | 434 | 462 | 1 |
| 3/31/2025 | 1,354 | 348 | 412 | 436 | 1 |
| 3/31/2024 | 1,393 | 316 | 443 | 497 | N/A |
| 12/31/2023 | 1,416 | 324 | 483 | 523 | N/A |
| 9/30/2023 | 1,439 | 331 | 523 | 550 | N/A |
| 6/30/2023 | 1,414 | 324 | 528 | 555 | N/A |
| 3/31/2023 | 1,389 | 316 | 534 | 561 | N/A |
| 12/31/2022 | 1,303 | 278 | 421 | 507 | N/A |
| 9/30/2022 | 1,217 | 239 | 309 | 453 | N/A |
| 6/30/2022 | 1,283 | 272 | 339 | 484 | N/A |
| 3/31/2022 | 1,350 | 305 | 369 | 514 | N/A |
| 12/31/2021 | 1,366 | 335 | 453 | 565 | N/A |
| 9/30/2021 | 1,382 | 365 | 537 | 616 | N/A |
| 6/30/2021 | 1,236 | 325 | 529 | 607 | N/A |
| 3/31/2021 | 1,090 | 285 | 520 | 598 | N/A |
| 12/31/2020 | 1,066 | 269 | 511 | 598 | N/A |
| 9/30/2020 | 1,043 | 253 | 502 | 599 | N/A |
| 6/30/2020 | 1,142 | 307 | 525 | 621 | N/A |
| 3/31/2020 | 1,241 | 360 | 548 | 644 | N/A |
| 12/31/2019 | 1,278 | 381 | 555 | 630 | N/A |
| 9/30/2019 | 1,315 | 402 | 563 | 616 | N/A |
| 6/30/2019 | 1,256 | 360 | 481 | 535 | N/A |
| 3/31/2019 | 1,197 | 319 | 400 | 453 | N/A |
| 12/31/2018 | 1,141 | 296 | 343 | 389 | N/A |
| 9/30/2018 | 1,084 | 272 | 286 | 324 | N/A |
| 6/30/2018 | 995 | 233 | 246 | 284 | N/A |
| 3/31/2018 | 906 | 194 | 206 | 244 | N/A |
| 12/31/2017 | 850 | 165 | N/A | 247 | N/A |
| 9/30/2017 | 793 | 135 | N/A | 251 | N/A |
| 6/30/2017 | 775 | 113 | N/A | 228 | N/A |
| 3/31/2017 | 757 | 91 | N/A | 205 | N/A |
| 12/31/2016 | 778 | 92 | N/A | 190 | N/A |
| 9/30/2016 | 798 | 93 | N/A | 174 | N/A |
| 6/30/2016 | 839 | 112 | N/A | 183 | N/A |
| 3/31/2016 | 879 | 130 | N/A | 192 | N/A |
| 12/31/2015 | 870 | 134 | N/A | 226 | N/A |
| 9/30/2015 | 861 | 139 | N/A | 260 | N/A |
| 6/30/2015 | 795 | 137 | N/A | 254 | N/A |
| 3/31/2015 | 729 | 135 | N/A | 247 | N/A |
| 12/31/2014 | 645 | 123 | N/A | 200 | N/A |
| 9/30/2014 | 562 | 112 | N/A | 154 | N/A |
| 6/30/2014 | 516 | 98 | N/A | 122 | N/A |
| 3/31/2014 | 470 | 83 | N/A | 91 | N/A |
| 12/31/2013 | 471 | 85 | N/A | 78 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: 1830Das prognostizierte Gewinnwachstum (11.6% pro Jahr) liegt über der Sparquote (2.3%).
Ertrag vs. Markt: 1830Die Erträge des Unternehmens (11.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Hong Kong (11.7% pro Jahr).
Hohe Wachstumserträge: 1830Die Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: 1830Die Einnahmen des Unternehmens (4.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Hong Kong (7.8% pro Jahr).
Hohe Wachstumseinnahmen: 1830Die Einnahmen des Unternehmens (4.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: 1830Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich sehr hoch sein (110%).